Metaproscaline

Last updated
Metaproscaline
Metaproscaline.png
Names
IUPAC name
2-(3,4-dimethoxy-5-propoxyphenyl)ethanamine
Identifiers
3D model (JSmol)
ChEMBL
ChemSpider
PubChem CID
UNII
  • InChI=1S/C13H21NO3/c1-4-7-17-12-9-10(5-6-14)8-11(15-2)13(12)16-3/h8-9H,4-7,14H2,1-3H3 Yes check.svgY
    Key: LRMHEQAATQTVRI-UHFFFAOYSA-N Yes check.svgY
  • InChI=1/C13H21NO3/c1-4-7-17-12-9-10(5-6-14)8-11(15-2)13(12)16-3/h8-9H,4-7,14H2,1-3H3
    Key: LRMHEQAATQTVRI-UHFFFAOYAS
  • COc1c(cc(cc1OCCC)CCN)OC
Properties
C13H21NO3
Molar mass 239.311 g/mol
Except where otherwise noted, data are given for materials in their standard state (at 25 °C [77 °F], 100 kPa).
Yes check.svgY  verify  (what is  Yes check.svgYX mark.svgN ?)

Metaproscaline, or 3,4-dimethoxy-5-propoxyphenethylamine, is a lesser-known psychedelic drug. It is an analog of proscaline. Metaproscaline was first synthesized by Alexander Shulgin. In his book PiHKAL (Phenethylamines i Have Known And Loved) , the dosage and the duration are unknown. [1] Metaproscaline produces few to no effects. Very little data exists about the pharmacological properties, metabolism, and toxicity of metaproscaline.

See also

References